According to PubChem data on BPC 157 , the peptide is associated with biological activity involving blood vessel growth and cellular migration
Specifically, a review of clinical trials on the use of BPC-157 has characterized it as safe both in treating inflammatory bowel disease and wound healing, noting that no events of toxicity had been reported throughout those trials [12]
For the foundational coverage of each compound individually, see What Is AOD-9604
Treatment plans, dosing protocols, and ongoing support are included
A5: No, fasting is not required before 5-Amino-1MQ Peptide Therapy
Those with Crohns disease, celiac disease, or other malabsorption disorders, which often hinder the bodys ability to absorb nutrients, might find B12 injections advantageous